Guiding the global evolution of cytogenetic testing for hematologic malignancies - Akkari, Yassmine M.N. (Departments of Cytogenetics and Molecular Pathology. Legacy Health (Estats Units d'Amèrica)) ; Baughn, Linda B. (Mayo Clinic) ; Dubuc, Adrian M. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Smith, Adam C. (University of Toronto) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Dal Cin, Paola (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Diez-Campelo, María (Instituto de Investigación Biomédica de Salamanca) ; Gallego, Marta S. (Italian Hospital) ; Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Haase, Detlef (University Medical Center Göttingen) ; Schlegelberger, Brigitte (Department of Human Genetics. Hannover Medical School) ; Slavutsky, Irma (Institute of Experimental Medicine) ; Mecucci, Cristina (Hematology University of Perugia) ; Levine, Ross L. (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Hasserjian, Robert P. (Massachusetts General Hospital (Boston)) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Levy, Brynn (Columbia University Medical Center) ; Xu, Xinjie (Mayo Clinic) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.